A phase III study of entecavir vs lamivudine in chronic hepatitis B subjects with incomplete response to lamivudine

Trial Profile

A phase III study of entecavir vs lamivudine in chronic hepatitis B subjects with incomplete response to lamivudine

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Apr 2011

At a glance

  • Drugs Entecavir; Lamivudine
  • Indications Hepatitis B
  • Focus Therapeutic Use
  • Acronyms BEHoLD
  • Most Recent Events

    • 01 Jul 2008 96-week results published in Hepatology.
    • 20 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top